Fintech investment in the Asia Pacific fell to levels not seen in more than a decade in 2025, as geopolitical tensions, uneven growth, and a cautious funding ...
Hyderabad: Drug development timelines have been compressed to three years, and the research and development costs have been ...
Report finds AI, automation and analytics adoption enabling faster trials, streamlined discovery, and lower R&D-to-launch costs across pharma GCCs ...
Pharma and life sciences GCCs reduce drug development timelines and costs by leveraging AI and automation, enhancing R&D efficiency.
KPMG reports that Asia Pacific fintech funding reached US$9.3 billion in 2025, with H2 data indicating the market may be ...
Bizcommunity on MSN
KPMG report: African financial sector bets big on AI and growth strategies
Financial services leaders across Africa are entering 2026 with renewed confidence, placing artificial intelligence (AI), cybersecurity, regulatory resilience and strategic growth at the heart of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results